Appeal No. 94-2592 Application 07/707,265 unpredictable, then it would not have been reasonable for one of ordinary skill in the art to expect success in producing either one. Rejection under 37 CFR § 1.196(b) Under the provisions of 37 CFR § 1.196(b) we make the following new ground of rejection. Claims 31 through 33 are rejected under 35 U.S.C. § 112, second paragraph, for failing to particularly point out and distinctly claim the subject matter which the appellants regard as the invention. Claims 31 through 33 are confusing and misdescriptive in the recitation of an eglin compound having the “amino acid sequence: N-acetyl-Thr. . . .” Since the “N-acetyl” is not an amino acid, it is not clear whether the appellants intend to claim just the eglin amino acid sequence or an “N-acetylated eglin.” An amendment inserting “N-acetylated” between “following” and “amino” on line 2 of claim 31 would obviate this rejection. A similar problem exists in withdrawn claim 34. Since the DNA sequence in paragraph a) encodes “said eglin compound,” it is not clear whether the appellants intend to 8Page: Previous 1 2 3 4 5 6 7 8 9 10 11 NextLast modified: November 3, 2007